Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Generic Pharma

MYL:US

73.3692 USD 0.6892 0.95%

As of 10:36:39 ET on 05/29/2015.

Snapshot for Mylan NV (MYL)

Open: 72.7300 Day's Range: 72.6500 - 73.4700 Volume: 1,690,194
Previous Close: 72.6800 52wk Range: 44.8000 - 76.6850 1-Yr Rtn: +46.75%

Stock Chart for MYL

No chart data available.
  • MYL:US 73.3600
  • 1D
  • 1M
  • 1Y
72.6800
Interactive MYL Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for MYL

Current P/E Ratio (ttm) 24.6294
Estimated P/E(12/2015) 17.6923
Relative P/E vs. SPX 1.3232
Earnings Per Share (USD) (ttm) 2.9510
Est. EPS (USD) (12/2015) 4.1080
Est. PEG Ratio 1.4566
Market Cap (M USD) 35,615.62
Shares Outstanding (M) 490.03
30 Day Average Volume 9,428,685
Price/Book (mrq) 3.9426
Price/Sale (ttm) 3.5608
Dividend Indicated Gross Yield -%
Cash Dividend (USD) -
Dividend Ex-Date 07/17/2007
5 Year Dividend Growth -
Next Earnings Announcement 08/07/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for MYL

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for MYL

Mylan NV is a global generic and specialty pharmaceuticals company. The Company operates an active pharmaceutical ingredient manufacturer and runs a specialty business focused on respiratory, allergy, and psychiatric therapies.

Robert J CouryChairmanRodney L PiattVice Chairman
Heather BreschChief Executive OfficerRajiv MalikPresident
More Company Profile & Key Executives for MYL

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil